RLX Technology Announces Unaudited First Quarter 2026 Financial Results
Stocks in this Quantisnow insightHealth Care
Historical context for RLX
Across the 7 sessions after earlier RLX headlines, the stock closed higher 3 times and lower 3 times, with a median move of 1.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | RLX | SPY |
|---|---|---|---|
| May 11, 2026 | RLX Technology to Report First Quarter 2026 Financial Results on May 20, 2026 | +2.4% | +0.2% |
| Apr 23, 2026 | RLX Technology Files 2025 Annual Report on Form 20-F | +0.0% | -0.4% |
| Mar 13, 2026 | RLX Technology Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results | -0.9% | -0.6% |
| Mar 3, 2026 | RLX Technology to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 13, 2026 | -2.1% | -0.9% |
| Dec 31, 2025 | RLX Technology Extends US$500 Million Share Repurchase Program | +1.7% | -0.7% |
| Nov 14, 2025 | RLX Technology Announces Unaudited Third Quarter 2025 Financial Results | +10.3% | -0.0% |
Quantisnow market dataNYSE
RLX
RLX Technology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Listed since
- 2021
Get push alerts for RLX
Full RLX profile on Quantisnow Follow RLX and get a push notification the moment its next story breaks.